Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 756 entries
Sorted by: Best Match Show Resources per page
Prolonged Response and Restoration of Functional Independence with Bevacizumab plus Vinorelbine as Third-Line Treatment for Breast Cancer-Related Leptomeningeal Metastases.

Case reports in oncology

Le Rhun E, Taillibert S, Boulanger T, Zairi F, Bonneterre J, Chamberlain MC.
PMID: 25848355
Case Rep Oncol. 2015 Feb 12;8(1):72-7. doi: 10.1159/000375293. eCollection 2015.

BACKGROUND: Survival of patients with leptomeningeal metastases (LM) and impaired functional status is limited to several months, and rarely does neurological function improve with treatment.CASE REPORT: A 34-year-old female with hormone-negative and HER2-positive metastatic breast cancer was diagnosed with...

Can BuCyE conditioning regimen be an alternative treatment to BEAM at autologous transplantation in malignant lymphoma patients?: a single center experience.

International journal of clinical and experimental medicine

Berber I, Erkurt MA, Nizam I, Koroglu M, Kaya E, Kuku I, Bag HG.
PMID: 26629149
Int J Clin Exp Med. 2015 Sep 15;8(9):16308-14. eCollection 2015.

High-dose chemotherapy (HDC) applied together with autologous stem cell transplantation (ASCT) is a commonly used treatment modality in patients with malignant lymphoma. At present, there is a limited number of studies which compare toxicity and efficacy of various high-dose...

Current approaches and advance in mantle cell lymphoma treatment.

Stem cell investigation

Liu Y, Zhang X, Zhong JF.
PMID: 27358886
Stem Cell Investig. 2015 Sep 29;2:18. doi: 10.3978/j.issn.2306-9759.2015.09.02. eCollection 2015.

Mantle cell lymphoma (MCL) is a set of heterogeneous non-Hodgkin lymphoma characterized by involvement of lymph nodes, spleen, bone marrow and blood. Under conventional treatment, survival time is 4 to 5 years with short remission period and there is...

GDP versus ESHAP Regimen in Relapsed and/or Refractory Hodgkin lymphoma: A Comparison Study.

International journal of hematology-oncology and stem cell research

Ramzi M, Rezvani A, Dehghani M.
PMID: 25802695
Int J Hematol Oncol Stem Cell Res. 2015 Jan 01;9(1):10-4.

BACKGROUND: Despite multiple published studies reporting result of salvage regimens for relapsed and refractory Hodgkin's lymphoma, there are no comparisons of different combinations.PATIENTS AND METHODS: A Total of 44 patients identified with refractory or relapsed Hodgkin's Lymphoma were considered...

Short-term therapeutic effects of low-dose cytarabine plus surgical resection on elderly patients with trigeminal nerve tumor and safety observation.

Pakistan journal of medical sciences

Li XS, Yang WL, Shen FZ, Gao GJ, Ma JW, Jin BZ.
PMID: 25878639
Pak J Med Sci. 2015 Jan-Feb;31(1):178-82. doi: 10.12669/pjms.311.6440.

OBJECTIVE: To evaluate the short-term therapeutic effects of low-dose cytarabine plus surgical resection on elderly patients with trigeminal nerve tumor and to observe the safety.METHODS: A total of 120 elderly patients with trigeminal nerve tumor were divided into a...

Vosaroxin in relapsed/refractory acute myeloid leukemia: efficacy and safety in the context of the current treatment landscape.

Therapeutic advances in hematology

Sedov V, Stuart RK.
PMID: 28567238
Ther Adv Hematol. 2017 Jun;8(6):185-195. doi: 10.1177/2040620717703012. Epub 2017 Apr 21.

Treatment for acute myeloid leukemia (AML) generally consists of a combination of cytarabine and an anthracycline. Although induction therapy leads to complete remission (CR) for most patients, refractoriness to chemotherapy or relapse after initial response is associated with poor...

Allogeneic stem cell transplantation can improve outcome of AML patients without complete cytogenetic response after induction and consolidation treatment.

Neoplasma

Dvorak P, Lysak D, Vokurka S, Karas M, Subrt I.
PMID: 25563378
Neoplasma. 2015;62(1):140-5. doi: 10.4149/neo_2015_018.

UNLABELLED: Our retrospective analysis was performed on 376 consecutive patients diagnosed with AML. A total of 256 (68%) were treated with standard "7+3" induction and high-dose cytarabine and mitoxantrone containing "4+3" consolidation/intensification regimens. Our study focused on patients with...

Neurocognitive outcomes and school performance in solid tumor cancer survivors lacking therapy to the central nervous system.

Journal of personalized medicine

Mohrmann C, Henry J, Hauff M, Hayashi RJ.
PMID: 25867598
J Pers Med. 2015 Apr 10;5(2):83-90. doi: 10.3390/jpm5020083.

School performance in patients who have received therapy for childhood cancers has been studied in depth. Risk factors have historically included cranial radiation, intrathecal chemotherapy, and high doses of chemotherapy, including methotrexate and cytarabine. Leukemia and brain tumor survivors...

Acute panmyelosis with myelofibrosis - a rare subtype of acute myeloid leukemia.

Mediterranean journal of hematology and infectious diseases

Chatterjee T, Gupta S, Sharma A, Sharma S, Gupta D.
PMID: 23795280
Mediterr J Hematol Infect Dis. 2013 Jun 04;5(1):e2013042. doi: 10.4084/MJHID.2013.042. Print 2013.

One case of acute panmyelosis with myelofibrosis (APMF) is here reported. A 45 year old male presented with abrupt onset of rapidly progressing low backache, weakness and pancytopenia. On examination there was no organomegaly. Peripheral blood examination revealed normocytic...

A case of Takotsubo cardiomyopathy after chemotherapy.

Oxford medical case reports

Malley T, Watson E.
PMID: 27066260
Oxf Med Case Reports. 2016 Apr 07;2016(4):55-8. doi: 10.1093/omcr/omw014. eCollection 2016 Apr.

Here we present the case of a patient with diffuse large B-cell lymphoma who was admitted to hospital for an elective autologous peripheral blood stem cell transplant after cytotoxic treatment with lomustine, cytarabine, cyclophosphomide and etoposide (LACE). On the...

A comparative study of idarubicin 12 mg/m(2) and 8 mg/m(2) combined with cytarabine as the first induction regimen for adult acute myeloid leukemia patients.

OncoTargets and therapy

Zhou L, Liu X, Liu H, Zhu W, Cai X, Song K, Zheng C, Tang B, Sun Z.
PMID: 27013891
Onco Targets Ther. 2016 Feb 29;9:985-91. doi: 10.2147/OTT.S96176. eCollection 2016.

OBJECTIVE: This study aimed to explore a suitable dose of idarubicin (IDA) combined with cytarabine for the initial induction regimen for acute myeloid leukemia (AML) patients.PATIENTS AND METHODS: A total of 100 adult patients with de novo AML aged...

Development of donor cell leukemia following peripheral blood stem cell transplantation for severe aplastic anemia: A case report.

Oncology letters

Ma H, Liu T.
PMID: 27313707
Oncol Lett. 2016 Jun;11(6):3858-3862. doi: 10.3892/ol.2016.4452. Epub 2016 Apr 18.

Donor cell leukemia (DCL) is a rare complication of hematopoietic stem cell transplantation (HSCT) which occurs in ~5% of all leukemic relapses. In the English literature, >60 cases of DCL have been reported, however, only two cases of DCL...

Showing 1 to 12 of 756 entries